Protein-energy malnutrition (PEM) and inflammation are common and usually concurrent in
maintenance dialysis patients. Many factors that appear to lead to these 2 conditions …

The first reports connecting uremic inflammation with a wasted and atherogenic phenotype
and poor outcome initiated in the late 1990s. Since then, about 3500 publications appear on …

Fatigue is a debilitating symptom or side effect experienced by many patients on long-term
dialysis therapy. Fatigue has a considerable effect on patient health-related quality of life …

Left ventricular hypertrophy (LVH) and inflammation independently increase risk for death in
people who receive hemodialysis. A nonrandomized, controlled trial was conducted of the …

Cardiovascular disease (CVD) remains the major cause of morbidity and mortality in end‐
stage renal disease (ESRD) patients. As traditional risk factors cannot alone explain the …

Inflammation is normally a protective and physiological response to harmful stimuli, but
typically becomes an uncontrolled, maladaptive, and persistent process in patients with end …

Background and aims Low serum albumin (SA) is associated with an increased risk of long-
term adverse events (AEs) among patients with chronic coronary syndromes. Its prognostic …

Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and
oxidative stress. Background Chronic inflammation and oxidative stress are highly prevalent …

Morbidity and mortality are markedly elevated in chronic kidney disease (CKD) patients as
consequence of cardiovascular risk factors clustering. Non-traditional risk factors such as …

End stage renal disease (ESRD, or kidney failure) affects∼ 10% of the world's population.
Kidney transplantation, which best duplicates native kidney function, can extend the …